Pharmacological therapy, slows the heart rate, in patientswith hypertension and chronic heart failure: theory and application in clinical practice

Pharmacological therapy, slows the heart rate, in patientswith hypertension and chronic heart failure: theory and application in clinical practice

The purpose of the study is to determine the spectrum used drugsslows the heart rate in patients with arterial hypertension and chronic heart failure in clinical practice and compliance of prescribing with clinical guidelines.Materials and methods. Consistently formed a retrospective sample of medic...

Full description

Bibliographic Details
Main Authors:	A I Ponomareva, O G Kompaniets, R M Linchak, G S Ivanchura
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2016-03-01
Series:	Системные гипертензии
Subjects:	therapy slows the heart rate -blockers calcium antagonists ivabradine
Online Access:	https://syst-hypertension.ru/2075-082X/article/viewFile/29135/pdf

Similar Items

Pharmacological therapy, slows the heart rate, in patients with hypertension and chronic heart failure: theory and application in clinical practice
by: Ponomareva A.I., et al.
Published: (2016-01-01)

Heart Rate Reduction and Outcomes in Heart Failure Outpatients
by: Felix Memenga, et al.
Published: (2023-10-01)

The role of heart rate and ivabradine in acute heart failure
by: Edoardo Sciatti, et al.
Published: (2019-10-01)

Practical Pharmacological Treatment of Heart Failure: Does Ejection Fraction Matter Anymore?
by: Jonathan C. H. Chan, et al.
Published: (2023-03-01)

IF CHANNEL INHIBITOR IVABRADINE AND CHRONIC HEART FAILURE MANAGEMENT: FROM DISCUSSION TO ACTION
by: Yu. M. Lopatin
Published: (2012-08-01)

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE IVABRADINE AND HEART RATE REDUCTION IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01)

Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease
by: E. I. Tarlovskaya, et al.
Published: (2016-03-01)

Differentiated approach to the use of optimal medical therapy in patients with various clinical forms of stable ischemic heart disease
by: I. I. Shaposhnik, et al.
Published: (2019-01-01)

Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease?
by: Alessandro Fucili, et al.
Published: (2021-09-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

Efficacy and safety evaluation of ivabradine in patients with non-ischemic heart failure
by: LIU Ying-xian, SONG Yan-jun, CHEN Wei, LIN Xue, LAI Jin-zhi, LI Jing-yi, WU Wei
Published: (2021-11-01)

Ivabradine in Chronic Heart Failure
by: Hadeer Eid, et al.
Published: (2020-06-01)

Features of diagnosis and treatment of patients with stable coronary artery disease at initially normal arterial pressure
by: I. I. Shaposhnik, et al.
Published: (2018-09-01)

Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01)

Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure
by: Korhan Soylu, et al.
Published: (2020-08-01)

Study evaluating the impact of a combination of inotropic support and heart rate monitoring on prognosis and stabilization rate in patients with decompensated chronic heart failure (LEGION)
by: Grigoriy Pavlovich Arutyunov, et al.
Published: (2010-03-01)

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure
by: Sherief Mansour, et al.
Published: (2011-06-01)

Epidemiologic surveillance on quality of life in patients with systolic heart failure after treatment with the selective heart rate inhibitor ivabradine
by: M Srinivasa Rao, et al.
Published: (2017-01-01)

TREATMENT OF EARLY STAGES OF HEART FAILURE
by: V. I. Vishnevsky
Published: (2001-02-01)

IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
by: Ying‐Hsiang Lee, et al.
Published: (2021-04-01)

Modern opportunities of heart rate regulation in coronary heart disease
by: N. Sh. Zagidullin, et al.
Published: (2013-10-01)

How to consider target heart rate in patients with systolic heart failure
by: Toshihide Izumida, et al.
Published: (2020-10-01)

Effectiveness and safety of ivabradine in Chinese patients with chronic heart failure: an observational study
by: Jingmin Zhou, et al.
Published: (2024-04-01)

The effect of ivabradine on hospitalization of heart failure patients: A retrospective cohort study
by: Sara Al-Balushi, et al.
Published: (2021-01-01)

THERAPEUTIC EFFECT ON HEART RATE: VISIBLE SIMPLICITY AND REAL DIFFICULTY
by: S. R. GILYAREVSKY, et al.
Published: (2016-12-01)

Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function
by: Giuseppe Cocco, et al.
Published: (2013-11-01)

Advances in the management of heart failure: the role of ivabradine
by: Müller-Werdan U, et al.
Published: (2016-11-01)

Chronic heart failure: actual aspects of treatment in real clinical practice
by: D. I. Trukhan, et al.
Published: (2019-10-01)

β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate
by: Jin Joo Park, et al.
Published: (2019-02-01)

Observational study of new-onset atrial fibrillation in patients treated with Ivabradine alone versus Ivabradine and β-blocker drug (The BetaBrad Study)
by: Rohan S Thanedar, et al.
Published: (2022-01-01)

Cost effectiveness analyses of pharmacological treatments in heart failure
by: Audrey Huili Lim, et al.
Published: (2022-09-01)

HCN Channels and Heart Rate
by: Ilaria Dentamaro, et al.
Published: (2012-04-01)

DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
by: M. V. Surovtseva, et al.
Published: (2012-12-01)

A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
by: David E. Lanfear, et al.
Published: (2020-08-01)

Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
by: Hadeer Eid, et al.
Published: (2020-12-01)

Early administration of ivabradine in patients admitted for acute decompensated heart failure
by: Teng-Yao Yang, et al.
Published: (2022-11-01)

Pathogenetic bases and efficacy of slow calcium channel blockers in the therapy of recurrent peptic ulcer disease associated with hypertension
by: L A Fomina, et al.
Published: (2017-02-01)